ONCOLYTIC VIRUSES FOR MODIFIED MHC EXPRESSION

ONCOLYTIC VIRUSES FOR MODIFIED MHC EXPRESSION

ONCOLYTIC VIRUSES AND METHODS OF USE THEREOF FOR THE TREATMENT OF CANCER

Dietary supplement composition for treating and managing acne

DIETARY SUPPLEMENT COMPOSITION FOR TREATING AND MANAGING ACNE

Compositions Comprising Microbes and Methods of Use and Making Thereof

Method for treating burns with brazilian green propolis

Methods of treating bleeding in a subject treated with an antiplatelet agent

Targeting the Tumor Microenvironment Using Manipulated NKT Cells

CRYSTALLINE POLYMORPHIC FORMS OF STING AGONISTS ASSOCIATED WITH METAL IONS CAPABLE OF MODULATING AN IMMUNE RESPONSE

17A-MONOESTERS AND 17A,21-DIESTERS OF CORTEXOLONE FOR USE IN THE TREATMENT OF TUMORS

SUPPRESSION OF COVID-19 REPLICATION BY COVID-19 ENTRY INHIBITORS

METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT

FORMULATIONS FOR TREATMENT OF POST-TRAUMATIC STRESS DISORDER

CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USE

COMBINATION THERAPY FOR TREATING CANCER

APPLICATION OF GANCICLOVIR IN PREPAPRATION OF MEDICINE FOR TREATING ALLERGIC RHINITIS

COMBINATION THERAPIES COMPRISING A METTL3 INHIBITOR AND A FURTHER ANTICANCER AGENT

USE OF SOS1 INHIBITORS WITH RAS INHIBITORS TO TREAT CANCERS

COMPOUNDS FOR THE TREATMENT OF GLIOBLASTOMA

Compositions And Methods For The Treatment Of Alopecia

Combination Therapy with AXL Inhibitor and Immune Checkpoint Modulator or Oncolytic Virus

METHODS AND COMPOSTITIONS FOR TARGETING PD-L1

COMPOUNDS

METHODS AND COMPOUNDS FOR THE TREATMENT OR PREVENTION OF HYPERCYTOKINEMIA AND SEVERE INFLUENZA

HISTAMINE RECEPTOR AGONISTS FOR CANCER THERAPY IN CANCER PATIENTS UNRESPONSIVE TO CANCER IMMUNOTHERAPY AND WITH ELEVATED MYELOID DERIVED SUPPRESSOR CELLS

Methods for treating heterotopic ossification

Asymmetric allyl tryptamines

METHODS OF TREATING APOL-1 DEPENDENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS

COMPOSITION COMPRISING A DIINDOLYLMETHANE AND A RETINOID TO TREAT A SKIN CONDITION

COMBINATION THERAPIES USING IMMUNO-DASH INHIBITORS AND PGE2 ANTAGONISTS

Vitro and Xenograft Anti-Tumor Activity of a Halogenated-Xanthene Against Refractory Pediatric Solid Tumors

Cannabidiol and active delivery systems

SPRAY DRYING OF API IN SUPERSATURATED SOLUTIONS WITH FORMIC ACID

SOL-GEL COMPOSITIONS FOR VETERINARY USE

ANTIMICROBIAL FERULIC ACID DERIVATIVES AND USES THEREOF

Building block for electro-optical integrated indium-phosphide based phase modulator

METHODS FOR ANALYSIS OF CELL-FREE NUCLEIC ACIDS IN URINE

COMPOSITION COMPRISING AN RNA THERAPEUTIC TARGETING FAT10 AND USES OF SAME FOR TREATING DISORDERS CHARACTERIZED BY ABNORMAL LIPID ACCUMULATION

MIRNA INHIBITORS FOR PREVENTING AND TREATING ANEURYSMS, HYPERTENSION, ARDS AND OTHER DISEASES ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION

Methods of Treating Cancer and Infectious Diseases Using Cell Based Therapies

DOSING FOR ANTI-TRYPTASE ANTIBODIES

Anti-CUB domain-containing protein 1 (CDCP1) antibodies, antibody drug conjugates, and methods of use thereof

COMBINATION THERAPIES TARGETING PD-1, TIM-3, AND LAG-3

ANTI-CD2 ANTIBODIES

BINDING AGENTS

Acute treatment and rapid treatment of headache using anti-CGRP antibodies

IL4/IL13 RECEPTOR MOLECULE FOR VETERINARY USE

THERAPEUTIC MOLECULES

MAGE-A VACCINES AND METHODS OF TREATMENT USING THE SAME

PEPTIDE FOR TREATING RETINITIS PIGMENTOSA

CARDIOPROTECTIVE LIPIDS AND METHODS OF USE

HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS

7-BENZYL-4-(2-METHYLBENZYL)-2,4,6,7,8,9-HEXAHYDROIMIDAZ0[1,2-A]PYRID0[3,4-E] PYRIMIDIN-5 (1 H)-ONE, ANALOGS THEREOF, AND SALTS THEREOF AND METHODS FOR THEIR USE IN THERAPY

UREA COMPOUNDS AND COMPOSITIONS AS SMARCA2/BRM ATPASE INHIBITORS

MACROCYCLIC HETEROCYCLES AND USES THEREOF

CDK19-Selective Inhibitors, and Methods of Use Thereof

DRG-MDM2-2 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2) INHIBITOR

HETEROCYCLIC COMPOUNDS CAPABLE OF ACTIVATING STING

Inhibitors of cysteine proteases and methods of use thereof

USE OF IMMUNE MODULATORS TO IMPROVE NERVE REGENERATION

THERAPEUTIC TARGETING OF CADHERIN 11 IN CANCER

METHODS OF USING GLYCOPOLYSIALYLATED THERAPEUTIC PROTEINS

TREATMENT FOR BONE DISEASES

GENETIC SWITCHES AND THEIR USE IN TREATING CANCER

PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES

METHODS OF TREATING AGE-RELATED FRAILTY WITH INTERLEUKIN-6

Dry powder formulation of caveolin-1 peptides and methods of use thereof

AMANITA MUSCARIA EXTRACTS AND COMPOUNDS AND THEIR BENEFICIAL AND THERAPEUTIC USE

FIBROBLAST BASED THERAPEUTICS OF AMYOTROPHIC LATERAL SCLEROSIS

METHODS FOR INDUCING AN IMMUNE RESPONSE BY ADMINISTERING ACTIVATED MESENCHYMAL STEM CELLS

Subject-Specific Tumor Inhibiting Cells and the Use Thereof

Methods and Compositions for Treatment of Intervertebral Disc Disease

COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM

Enhancement of Anti-Angiogenic Cancer Immunotherapy by Abortogenic Agents

MMP13 AS A THERAPEUTIC TARGET FOR ALLERGIC INFLAMMATORY DISEASES

LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION HEART FAILURE WITH PRESERVED EJECTION FRACTION (PH-HFpEF)

COMPOSITIONS AND METHODS FOR TREATING POLYCYTHEMIA

METHODS OF TREATING CORONAVIRUS INFECTIONS BY CO-ADMINISTERING AN FKBP LIGAND AND AN ANTIVIRAL AGENT

METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL CONDITIONS

METHODS OF REDUCING ACNE AND ROSACEA RELAPSE RATE AND SEVERITY

PYRAZOLONE COMPOUNDS FOR USE IN DEGENERATIVE RETINAL DISEASES

METHODS AND COMPOSITIONS FOR TREATING OCULAR NEOVASCULAR DISEASE

Compositions comprising aticaprant

Taxane Analogs for the Treatment of Brain Cancer

USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF HYPERTENSION IN NON-HUMAN MAMMALS

COMPOSITIONS COMPRISING MEDIUM ODD CHAIN LIPIDS WITH MULTIFUNCTIONAL ACTIVITY TO PREVENT AND TREAT SKIN INFLAMMATION AND AGING

METHODS AND COMPOSITIONS FOR TREATING CANCER

Rapid Onset Therapeutic Ketosis Enabled by D-BetaHydroxyButyric Acid Systems, Compounds and Methods for Sepsis Protection and Enhanced Medical Recovery

Rapid Onset Therapeutic Ketosis Enabled by D-BetaHydroxyButyric Acid Systems, Compounds and Methods for Stroke medication co-administration

MYRCENE-CONTAINING COMPLEX MIXTURES TARGETING TRPV1

COMPOSITIONS COMPRISING SUPERFINE COMPOUNDS AND PRODUCTION THEREOF

High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients

USE OF CYP450 INHIBITOR IN INHIBITING OR KILLING MITES AND TREATING XEROPHTHALMIA

Compositions and Methods for Identifying and Modulating Metabolic Health

BIOMARKER FOR PREDICTING RESPONSE TO CANCER TREATMENT

COMPOSITION FOR PREVENTING OR TREATING OF ISCHEMIC CEREBROVASCULAR DISEASE COMPRISING AN ARGINASE-1 INHIBITOR

CD274 MUTATIONS FOR CANCER TREATMENT

MULTI-SPECIFIC ANTIBODY CONSTRUCTS AGAINST THE MUC1-C/EXTRACELLULAR DOMAIN (MUC1-C/ED)

DIAGNOSTIC INDICATORS AND THERAPEUTIC TARGETS OF RHEUMATOID ARTHRITIS

METHODS FOR TREATING HYPERTENSION USING AN ANTI-BMP10 MONOCLONAL ANTIBODY OR FRAGMENT THEREOF

Preparation method and application of high-purity plant-derived recombinant human serum albumin

KIDNEY ACTIVE FUSION PROTEINS AND METHODS OF TREATMENT USING THE SAME

Surface layer protein a (SlpA) as a therapeutic agent for the treatment of inflammatory diseases

NOVEL UNIVERSAL ANTI-RNA VIRUS AGENTS

Functionalized heterocycles as antiviral agents

SYSTEMS, DEVICES AND METHODS FOR THE CREATION OF A THERAPEUTIC RESTRICTION IN THE GASTROINTESTINAL TRACT

COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO THE HEPATOPANCREATIC ANATOMICAL REGION

PRODUCTS AND METHODS FOR TREATING MUSCULAR DYSTROPHY

TARGETING CANCER CELLS AND TISSUE USING FILAMENTOUS PLANT VIRUS PARTICLES

PRESERVATIVE SYSTEMS

FAST-ACTING PLANT-BASED MEDICINAL COMPOUNDS AND NUTRITIONAL SUPPLEMENTS

PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

Trim proteins and galectins cooperate and codirect autophagy and are useful in the treatment of autophagy related diseases

USE OF CLOSTRIDIUM HISTOLYTICUM PROTEASE MIXTURE IN PROMOTING WOUND HEALING

Hyaluronidase Enzyme Formulations for High Volume Administration

PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES

FIBROBLAST GROWTH FACTOR-21-FC FUSION PROTEINS

TREATMENT OF BETA-CELL FAILURE OR DYSFUNCTION

METHODS OF TREATING AND PREVENTING CANCER TREATMENT SIDE EFFECTS

COMPOSITIONS AND METHODS FOR THE TREATMENT OF BONE AND JOINT DISEASES

Cutibacterium Acnes Biomimetic, Prebiotic, Probiotic and Postbiotic Compositions for Treatment of Skin Conditions

TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND LUNG DEGENERATION USING ACTIVATED FIBROBLASTS AND EXOSOME DERIVATIVES THEREOF

NOVEL TARGETS FOR ENHANCING ANTI-TUMOR IMMUNITY

KIT FOR PREVENTING OR TREATING FILOVIRUS AND FLAVIVIRUS DISEASES

Method and compositions for treating animal viral infections

METHODS OF TREATING OR PREVENTING ALLERGIES AND CHRONIC NASAL CONGESTION

OILY FORMULATIONS OF CANNABINOIDS

TERPENE-ENRICHED CANNABINOID COMPOSITION FOR TREATING CONDITIONS AND/ OR SYMPTOMS ASSOCIATED WITH A STRESSFUL EVENT

METHODS OF TREATING CONGENITAL ADRENAL HYPERPLASIA

COMPOSITION CONTAINING LAMOTRIGINE, AND PREPARATION METHOD AND USE THEREOF

Ophthalmic Compositions and/or Methods for Presbyopia, Mydriasis and/or Ocular Discomfort Management

SOTORASIB DOSING REGIMEN

INTERMITTENT DOSING OF MDM2 INHIBITOR

COMPOUNDS AND METHODS TO SENSITIZE CANCER CELLS TO TYROSINE KINASE INHIBITORS

Inhibition of dipeptide repeat proteins

METHODS AND KITS FOR PREDICTING THE EFFICACY OF MIDOSTAURIN FOR THE TREATMENT OF CANCER

DIHYDROMYRICETIN NANOEMULSION FORMULATIONS AND METHODS FOR FORMING THEM

COMPOSITIONS AND METHODS OF USE OF PHORBOL ESTERS

ANESTHETIC COMPOUNDS AND METHODS OF MAKING AND USING SAME TO TREAT OR PREVENT PAIN SYMPTOMS

METHOD OF TREATING DRUG RESISTANT EPILEPSY

INSECT, ACARINA AND NEMATODE PEST CONTROL

TREATMENT METHODS HAVING REDUCED DRUG-RELATED TOXICITY AND METHODS OF IDENTIFYING THE LIKELIHOOD OF PATIENT HARM FROM PRESCRIBED MEDICATIONS

METHODS FOR PREDICTING AND TREATING CHEMORESISTANCE IN SMALL CELL LUNG CANCER PATIENTS

METHODS OF IDENTIFYING AND TREATING TUMORS WITH SIGMA1 INHIBITORS

DIAGNOSTIC FOR SEPSIS ENDOTYPES AND/OR SEVERITY

COMPOSITIONS AND METHODS OF TARGETING THE PAX6 SIGNALING PATHWAY TO REDUCE FORMATION OF AMYLOID BETA PLAQUES AND NEUROFIBRILLARY TANGLES

SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION FACTOR 6 (STAT6) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders

Human Anti-SOD1 Antibodies

COMPOSITIONS AND METHODS FOR TREATING LUNG CANCER

COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES BY INHIBITING FSH

Neoantigens Expressed In Ovarian Cancer And Their Uses

POLYMORPHIC FORM OF TG02 FOR TREATING CANCER

POLYMORPHIC FORM OF TG02 FOR TREATING CANCER

SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINES AS BRUTON'S TYROSINE KINASE MODULATORS

SOLID FORMS OF AN HIV CAPSID INHIBITOR

TOLL LIKE RECEPTOR MODULATOR COMPOUNDS

SELECTIVE, PARTIAL, AND ARRESTIN-BIASED 5-HT2A AGONISTS WITH UTILITY IN VARIOUS DISORDERS

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha

DERIVATIVES OF CANNABIDIOL-C4 FOR THE TREATMENT OF EPILEPSY

RADIOLABELED ETHER DENDRIMER CONJUGATES FOR PET IMAGING AND RADIOTHERAPY

FOLATE RECEPTOR-TARGETED RADIOTHERAPEUTIC AGENTS AND THEIR USE

GENE THERAPY FOR WET AGE-RELATED MACULAR DEGENERATION USING IPSC-DERIVED CELLS AS VECTORS

ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER

COMPOSITIONS, GELS AND FOAMS WITH RHEOLOGY MODULATORS AND USES THEREOF

COMPOSITIONS, GELS AND FOAMS WITH RHEOLOGY MODULATORS AND USES THEREOF

Adjuvant treatment of HER2-positive breast cancer

METHODS OF USING ACTIVIN RECEPTOR TYPE II SIGNALING INHIBITORS

CO-EXPRESSION OF CONSTRUCTS AND IMMUNOINHIBITORY COMPOUNDS

COMPOSITIONS AND METHODS FOR PROMOTING THE MINERALIZATION OF BIOLOGICAL TISSUE

PHARMACEUTICAL COMPOSITION CONTAINING SPECIFIC SELF-ASSEMBLING PEPTIDE RADA16 FOR TREATING OR PREVENTING LOWER GASTROINTESTINAL DISEASES SUCH AS INFLAMMATORY BOWEL DISEASE

Compositions and Methods for Treating Persistent Postsurgical Pain

COMPOSITIONS AND METHODS FOR TREATING RESPIRATORY DISTRESS

USE OF CNS-HOMING TARGETING PEPTIDES FOR TREATING NEUROLOGICAL DISORDERS

COMPOSITION FOR INHIBITING PROLIFERATION OF TUMOR COMPRISING RUBUS COREANUS EXTRACT AS EFFECTIVE COMPONENT

ENGINEERED S. TYPHIMURIUM AND USES THEREOF

COMPOSITIONS AND METHODS TO TRANSFECT, TEST, AND TREAT SKIN CELLS

METHODS OF CELL THERAPIES

CHIMERIC ANTIGEN RECEPTOR TO TARGET HLA-G-POSITIVE CANCERS

METHODS AND COMPOSITIONS FOR PANCREATIC CANCER EVALUATION AND TREATMENT

COMPOSITIONS CONTAINING VERTEPORFIN, RIBAVIRIN, GEMCITABINE, OR COMBINATIONS THEREOF AND METHODS OF USE FOR TREATING COVID-19, CANCER, OR NON CANCER DISEASES

ORALLY ADMINISTRABLE FORMULATIONS FOR THE CONTROLLED RELEASE OF A PHARMACOLOGICALLY ACTIVE AGENT

COMBINATION BPH THERAPY WITH FEXAPOTIDE TRIFLUTATE, A 5-ARI, AND AN ALPHA BLOCKER

Pharmaceutical compositions comprising (2S)-n-{(1S)-1-cyano-2-[4-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl)phenyl]ethyl}-1,4-oxazepane-2-carboxamide

SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF

ALGOSTATIC AGENTS FOR PREVENTING TRANSITION FROM ACUTE TO CHRONIC PAIN

Methods and Compositions for Treating Vasomotor Symptoms

USE OF SUBLINGUAL DEXMEDETOMIDINE FOR THE TREATMENT OF AGITATION

TREATMENT OF TUNNELING WOUNDS USING METRONIDAZOLE-CONTAINING COMPOSITIONS

Cyclohexylglycine derivatives as selective cytotoxic agents

TREATMENT AND DIAGNOSIS OF MELANOMA

Treatment or Prevention of Ischaemia Reperfusion Injury

PHARMACEUTICAL COMPOSITION FOR IMPROVING RESPIRATORY DAMAGE AND USE FOR MANUFACTURING PHARMACEUTICAL COMPOSITION FOR IMPROVING RESPIRATORY DAMAGE

Membrane Encapsulated Nanoparticles and Method of Use

Cationic lipid compound, composition containing same and use thereof

EXTENDED-WEAR SILICONE HYDROGEL CONTACT LENSES AND USES THEREOF

Silk Protein Fragment Compositions and Articles Manufactured Therefrom

VITAMIN C RENAL LEAK AS A CLINICAL DIAGNOSTIC TOOL IN THE DETECTION, MONITORING, AND MANAGEMENT OF ACUTE AND CHRONIC DISEASES

BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS

Serotonin transporter gene and treatment of opioid-related disorders

THERAPEUTIC STRATEGY FOR NON-SMALL CELL LUNG CANCER AND OTHER CANCERS

Compositions and Methods for Enhancing Body Weight and Lean Muscle Mass Using Antagonists Against Leptin Receptor, GDF8 and Activin A

CELL-PENETRATING ANTI-DNA ANTIBODIES AND USES THEREOF INHIBIT DNA REPAIR

VASOACTIVE INTESTINAL PEPTIDE (VIP) RECEPTOR ANTAGONISTS

BTLA Fusion Protein Agonists and Uses Thereof

LAG-3 PROTEIN MUTANT, AND PREPARATION AND USE THEREOF

TARGETED DELIVERY OF TERTIARY AMINE-CONTAINING DRUG SUBSTANCES

CDK Inhibitors And Their Use As Pharmaceuticals

Compounds and methods for treatment of viral infections

SMALL MOLECULE INHIBITORS OF KRAS G12C MUTANT

BIFUNCTIONAL COMPOUNDS AND PHARMACEUTICAL USES THEREOF

Heterocyclic GLP-1 agonists

7-Morpholino-L,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK Inhibitor

BENZAMIDE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER CONTAINING SAME AS ACTIVE INGREDIENT

SUBSTITUTED 4-(3-AMINOPROP-1-YL)AMINOQUINOLINE ANALOGS AS MODULATORS OF MELANOMA-ASSOCIATED ANTIGEN 11 UBIQUITIN LIGASE

COMPOUNDS AS PD1/PD-L1 INHIBITORS AND METHODS THEREOF

EBNA1 Inhibitors and Methods Using Same

SYSTEM AND METHODS FOR TREATING CANCER CELLS WITH ALTERNATING POLARITY MAGNETIC FIELDS

Expression of Bacterial Dinucleotide Cyclases

NANOPARTICLE AND USE THEREOF FOR THE COMBINATORIAL THERAPY OF ENDOPLASMIC RETICULUM STRESS INDUCER AND IMMUNOTHERAPEUTIC TO TUMORS AND IMMUNE CELLS

PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

Treatments to cancers /tumors also skin aligments /rushes

FRACTIONATED RADIOTHERAPY AND CHEMOTHERAPY WITH AN OXYGEN THERAPEUTIC

SIALYLATED GLYCOPROTEIN COMPOSITIONS AND USES THEREOF

STRONGLY HYDROPHILIC MICRONEEDLE SUBSTRATE AND DRUG-LOADED MICRONEEDLE AND USE THEREOF IN TREATMENT OF DISEASES

USE OF CINNAMOMUM ZEYLANICUM ESSENTIAL OIL (EO) AS HUMAN MELANOMA CELLS DEATH INDUCER AND AS POSSIBLE ADJUVANT IN PHARMACOLOGICAL THERAPIES

PHARMACEUTICAL KIT AND USES THEREOF

COMPOSITIONS AND METHODS FOR REDUCING BLOOD ALCOHOL CONTENT

Device and Methods for Platelet Lysis or Activation

SYNERGISTIC FORMULATIONS OF ADENOSINE RECEPTOR MODULATING AGENTS AND ANTICHOLINERGICS

TOPICAL APPLICATION OF AGENTS TO REDUCE SUN SENSITIVITY AND IMPROVE TOPICAL PHOTODYNAMIC THERAPY

Inhibition of Lysine Demethylase 1 (Lsd1) Induces Differentiation of Hair Cells

METHODS OF TREATING PRADER WILLI SYNDROME AND CONDITIONS ASSOCIATED WITH LOW BASAL METABOLIC RATE OR HYPERPHAGIA USING A KATP CHANNEL OPENER

PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

COMPOSITIONS AND METHODS OF TISSUE REGENERATION THERAPY

2-METHYLENE-4-OXO-BUTANOIC ACID DERIVATIVES FOR THE TREATMENT OF INFLAMMATION

Treatment of Respiratory Diseases

NITRIC OXIDE RELEASING PHOSPHODIESTERASE TYPE 5 INHIBITOR

COMPOSITIONS AND METHODS RELATING TO INHIBITORS OF PRO-INFLAMMATORY FACTORS FOR TREATMENT OF CANCER

Methods of Treating Retinal Vasculopathies

Papain-like protease (PLpro) inhibitors

Choline Salt Forms of an HIV Capsid Inhibitor

AGENT FOR TREATING OR PREVENTING GLAUCOMA INCLUDING A SULFONAMIDE COMPOUND AND ANOTHER DRUG

DOSING REGIMENS

METHODS OF USING USP15 INHIBITORS

Methods of Treating Cushing's Syndrome and Liver Disorders, and of Reducing Liver Toxicity of Other Drugs Administered to a Patient

TAAR1 AND SEROTONIN MODULATORS, AND PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR TREATING SEPSIS

METHODS AND COMPOSITIONS FOR MANAGING PAIN COMPRISING DEXMEDETOMIDINE TRANSDERMAL COMPOSITIONS

ASH1L INHIBITORS AND METHODS AND TREATMENT THEREWITH

Animal Feeds and Feed Premixes Containing Betaine Hydrochloride and a Phytase

METHODS OF TREATING LENNOX-GASTAUT SYNDROME USING FENFLURAMINE

USE OF ATOVAQUONE AND PROGUANIL FOR REDUCING STEROID USE, ALL-CAUSE HOSPITALIZATION, OR ADVANCED THERAPY USE IN A SUBJECT DIAGNOSED WITH INFLAMMATORY BOWEL DISEASE, CROHN'S DISEASE, OR ULCERATIVE COLITIS

COMPOSITIONS AND METHODS FOR HEALTH COMPRISING CO-ENZYME Q10

COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF SURGICAL SITE INFECTIONS

LIQUID COMPOSITIONS

TOPICAL USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS

CONTAINERS WITH SELECTIVE DISSOLVED GAS CONTENT

PREDICTIVE PERIPHERAL BLOOD BIOMARKER FOR CHECKPOINT INHIBITORS

METHODS OF ADMINISTERING MONOMETHYL FUMARATE AND PRODRUGS THEREOF HAVING REDUCED SIDE EFFECTS

COMPOSITIONS AND THERAPEUTIC METHODS OF MICRORNA GENE DELIVERY

ANTISENSE OLIGONUCLEOTIDES TARGETING ADENOSINE KINASE

HUMAN CD163 ANTIBODIES AND USES THEREOF

Antagonistic CD40 Monoclonal Antibodies and Uses Thereof

PATCHED-1 MONOCLONAL ANTIBODIES AND METHODS OF USE

METHODS AND COMBINATIONS FOR THE TREATMENT OF CANCER USING IMMUNE CHECKPOINT INHIBITOR ANTIBODIES

ANTIBODIES FOR TREATING CANCER

METHODS OF TREATING HOMOLOGOUS RECOMBINATION DEFICIENT CANCER

MONOCLONAL ANTIBODIES TO GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15)

Treatment of headache using anti-CGRP antibodies

Fully Human Monoclonal Antibodies that Broadly Neutralize SARS-COV-2

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

KRAS INHIBITORS AND PHARMACEUTICAL USES THEREOF

(S)-1-(5-((PYRIDIN-3-YL)THIO)PYRAZIN-2-YL)-4'H,6'H-SPIRO[PIPERIDINE-4,5'-PYRROLO [1,2-B]PYRAZOL]-4'-AMINE DERIVATIVES AND SIMILAR COMPOUNDS AS SHP2 INHIBITORS FOR THE TREATMENT OF E.G. CANCER

NOVEL AZAINDOLE DERIVATIVES AS ANTIVIRAL AGENTS

MODULATORS OF BCL-2 OR BCL-2/BCL-XL AND USES THEREOF

7-Morpholino-1,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK Inhibitor

SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT

MODIFIED FERROPORTIN INHIBITORS

ACID ADDITION SALT OF ROCK INHIBITOR, AND CRYSTAL FORM, COMPOSITION AND PHARMACEUTICAL USE THEREOF

PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES

Chimeric Antigen Receptor-Modified NK-92 Cells

COMPOUNDS TARGETING FIBROBLAST-ACTIVATION PROTEIN AND METHODS OF USE THEREOF

INHIBITORS AND USES THEREOF

EXTRACELLULAR VESICLE-DIRECTED POLYPEPTIDE TAG

COMPOSITIONS INCLUDING CONJUGATED THERAPY ENHANCERS

Bispecific Antibody-Drug Conjugate

HSD17B13 Inhibitors and/or Degraders

HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY

DOSAGE FORMS OF TISSUE KALLIKREIN 1

METHODS FOR TREATING AND PREVENTING NEUTROPHIL-DERIVED NET TOXICITY AND THROMBOSIS

METHODS AND COMPOSITIONS FOR INDUCING BROWN ADIPOGENESIS

Use of Erythropoietin (EPO) or Erythropoiesis-Stimulating Agent (ESA) to Treat Osteomyelitis, Bone Infection, and Bone Inflammation

HIP/PAP PROTEIN OR A DERIVATIVE THEREOF FOR TREATING PERIPHERAL NEUROPATHY

METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1

A Biological Entity for Treating Brain Cancer

PROBIOTIC COMPOSITIONS AND USES THEREOF

MODIFIED NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS FOR CORONA AND OTHER VIRUSES

TREATMENT OF INFECTIONS IN AND AROUND THE EYE